Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Psychiatry Clin Neurosci ; 67(5): 352-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23859664

ABSTRACT

AIM: To investigate prevalence and patterns of psychiatric disorders in young subjects with Internet addiction (IA). METHODS: Subjects were taken from a sample of patients, aged 10-18 years old, referred to Istanbul Medical Faculty, Child and Adolescent Psychiatry Department due to a variety of behavioral and emotional problems alongside problematic Internet use. Inclusion criteria included IQ ≥70 and score ≥80 on Young's Internet Addiction Scale (YIAS). Psychiatric comorbidity was assessed using the Turkish version of the Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version. RESULTS: Subjects were 45 boys (75%) and 15 girls (25%) with an age range of 10-18 years old (mean age, 13.38 ± 1.79 years). A total of 60% (n = 36) had been using Internet for ≥5 years. Mean hours/week spent on the Internet was 53.7 (range, 30-105 h) and the average YIAS score was 85. All subjects (100%) had at least one and 88.3% (n = 53) had at least two comorbid psychiatric disorders. The frequency of diagnostic groups were as follows: behavioral disorder, n = 52 (86.7%); anxiety disorder, n = 43 (71.7%); mood disorder, n = 23 (38.3%); elimination disorder, n = 16 (26.7%); tic disorder, n = 10 (16.7%); and substance use disorder, n = 4 (6.7%). The most common psychiatric disorders were attention-deficit hyperactivity disorder (n = 53; 83.3%), social phobia (n = 21; 35.0%) and major depressive disorder (n = 18; 30.0%). CONCLUSION: High rates of psychiatric comorbidity, particularly behavioral, anxiety and mood disorders were found in young subjects with IA. Because the presence of psychiatric disorders may affect the management /prognosis of IA, assessment should include that for other psychiatric disorders.


Subject(s)
Behavior, Addictive/epidemiology , Behavior, Addictive/psychology , Internet , Adolescent , Adolescent Behavior , Anxiety Disorders/complications , Anxiety Disorders/epidemiology , Child , Comorbidity , Diagnostic and Statistical Manual of Mental Disorders , Female , Humans , Male , Mental Disorders/epidemiology , Mental Disorders/etiology , Mental Disorders/psychology , Mood Disorders/complications , Mood Disorders/diagnosis , Mood Disorders/epidemiology , Mood Disorders/psychology , Neuropsychological Tests , Prevalence , Psychiatric Status Rating Scales , Socioeconomic Factors , Tic Disorders/complications , Tic Disorders/epidemiology , Turkey/epidemiology
3.
Isr J Psychiatry Relat Sci ; 41(2): 118-24, 2004.
Article in English | MEDLINE | ID: mdl-15478457

ABSTRACT

Several studies have examined the relationship between dissociation and alexithymia. In this study, the objective was to investigate whether there was a relationship between alexithymia, dissociation and state and trait anxiety in psychiatric outpatients. The evaluations of psychiatric outpatients (n=154) were based on the Toronto Alexithymia Scale, the Dissociative Experiences Scale and the State and Trait Anxiety Index. The data were analyzed using chi2 test and multiple covariance analyses. Subjects with alexithymia (46.8%) were significantly less educated and showed higher state and trait anxiety. The mean Toronto Alexithymia Scale total score of the female and male patients was similar. The mean Dissociative Experiences Scale score of the study group was 10.8 (sd=9.8, ranged 0 to 45). A multivariate analysis of covariance showed that state and trait anxiety was a significant covariant for the Toronto Alexithymia Scale-Difficulty Identifying Feelings subscale. Only the trait anxiety was a significant covariant for the Toronto Alexithymia Scale-Difficulty Expressing Feelings subscale. The overall main effect of dissociation was not significant on the Toronto Alexithymia Scale total and subscales. These data suggest that dissociation is fundamentally a different construct from alexithymia, while state and trait anxiety are closely related to alexithymia.


Subject(s)
Affective Symptoms/ethnology , Anxiety/ethnology , Dissociative Disorders/ethnology , Adult , Affective Symptoms/diagnosis , Anxiety/diagnosis , Dissociative Disorders/diagnosis , Female , Humans , Male , Mental Disorders/diagnosis , Mental Disorders/ethnology , Mental Disorders/rehabilitation , Surveys and Questionnaires , Turkey
4.
In Vivo ; 18(3): 377-90, 2004.
Article in English | MEDLINE | ID: mdl-15341194

ABSTRACT

The dominant research subject on schizophrenia, mood disorders, autism and other central nervous system diseases has been related to neurotransmitter system abnormalities. For example, the dopamine hypothesis states that schizophrenia is the result of dopaminergic hyperactivity. The therapeutic approach has also been directed towards finding agents which will modulate or regulate these neurotransmitter systems at any step. There is substantial and mounting evidence that subtle abnormalities of reactive oxygen species (ROS) and nitric oxide (NO) may underlie a wide range of neuropsychiatric disorders. NO has chemical properties that make it uniquely suitable as an intracellular and intercellular messenger. It is produced by the activity of nitric oxide synthases which are present in peripheral tissues and in neurons. On the other hand, NO is known to be an oxygen radical in the central and peripheral nervous systems. NO has been implicated in a number of physiological functions such as noradrenaline and dopamine releases, memory and learning and certain pathologies such as schizophrenia, bipolar disorder and major depression. Evidence has been considered here for the proposal that an abnormality of NO metabolism may be a contributory factor in some neuropsychiatric disorders. The direct evidence for NO abnormalities in schizophrenia and other psychiatric disorders remains relatively limited to date, although there are some clinical and experimental studies. The suggestion that NO and other ROS may play a role in some neuropsychiatric disorders clearly has important implications for new treatment possibilities. The primary objective of the present review was to summarize and critically evaluate the current knowledge regarding a potential contribution of NO to the neuropathophysiology of schizophrenia as well as other neuropsychiatric disorders.


Subject(s)
Central Nervous System Diseases/physiopathology , Nitric Oxide/physiology , Psychotic Disorders/physiopathology , Animals , Central Nervous System Diseases/psychology , Disease Models, Animal , Humans , Models, Biological , Parkinson Disease/physiopathology
5.
Eur Arch Psychiatry Clin Neurosci ; 254(3): 143-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15205966

ABSTRACT

There is great evidence in recent years that oxygen free radicals play an important role in the pathophysiology of many neuropsychiatric disorders. The present study was performed to assess the changes in red blood cells thiobarbituric acid-reactive substances (TBARS) levels, and superoxide dismutase (SOD), catalase (CAT), adenosine deaminase (ADA) and xanthine oxidase (XO) activities in patients with autism (n = 27) compared to age- and sex-matched normal controls (n = 26). In the autistic group, increased TBARS levels (p < 0.001) and XO (p < 0.001) and SOD (p < 0.001) activity, decreased CAT (p < 0.001) activity and unchanged ADA activity were detected. It is proposed that antioxidant status may be changed in autism and this new situation may induce lipid peroxidation. These findings indicated a possible role of increased oxidative stress and altered enzymatic antioxidants, both of which may be relevant to the pathophysiology of autism.


Subject(s)
Autistic Disorder/blood , Erythrocytes/enzymology , Free Radical Scavengers/blood , Oxidative Stress/physiology , Adenosine Deaminase/blood , Autistic Disorder/physiopathology , Case-Control Studies , Catalase/blood , Child , Child, Preschool , Female , Humans , Male , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/metabolism , Xanthine Oxidase/blood
6.
Clin Chim Acta ; 331(1-2): 111-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12691871

ABSTRACT

BACKGROUND: There is evidence that oxygen free radicals play an important role in the pathophysiology of many neuropsychiatric disorders. Although it has not been investigated yet, several recent studies proposed that nitric oxide (NO) and other parameters related to oxidative stress may have a pathophysiological role in autism. METHODS: We assessed the changes in superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activities and thiobarbituric acid-reactive substances (TBARS) levels in plasma as well as NO levels in red blood cells (RBC) in patients with autism (n=27) compared to age- and sex-matched normal controls (n=30). RESULTS: In the autistic group, increased RBC NO levels (p<0.0001) and plasma GSH-Px activity (p<0.0001) and unchanged plasma TBARS levels and SOD activity were detected. CONCLUSIONS: These findings indicate a possible role of increased oxidative stress and altered enzymatic antioxidants, both of which may be relevant to the pathophysiology of autism.


Subject(s)
Autistic Disorder/blood , Glutathione Peroxidase/blood , Nitric Oxide/blood , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/metabolism , Autistic Disorder/enzymology , Child , Child, Preschool , Erythrocytes/metabolism , Female , Humans , Male , Oxidative Stress
7.
Neuropsychobiology ; 46(2): 61-6, 2002.
Article in English | MEDLINE | ID: mdl-12378121

ABSTRACT

The purpose of this study was to assess the significance of the hippocampal volume differences and its relation with risperidone treatment in schizophrenia. In schizophrenic patients who were on risperidone treatment (n = 11) and in healthy volunteers (n = 11), volumes of the hippocampi were estimated using magnetic resonance images (MRIs). A detailed systematic series of coronal MRIs of the entire brain (3 mm thickness, T(1)-weighted, TR/TE 400/10 ms) was obtained for each subject. All estimations were done according to Cavalieri's method by a modified point-counting grid placed on surface areas of hippocampal slices. The mean right and left hippocampal volumes in schizophrenics and control subjects were 1059.4 and 1003.2 mm(3), and 1780.1 and 1589.1 mm(3), respectively. The corresponding coefficients of errors were 0.05 and 0.068, and 0.059 and 0.081, respectively. The volumes of left and right hemispheres were not significantly different in both schizophrenic patients and controls (p > 0.05). However, a statistically significant difference (p < 0.05) was found between hippocampal volumes of the schizophrenic patients and controls. In conclusion, the hippocampal volume of the schizophrenic patients is significantly smaller than of the healthy controls. The patients who responded well to risperidone treatment had significantly greater hippocampal volumes than the patients who did not respond properly. Thus, hippocampal volume may be a predictor of the treatment response of schizophrenics to risperidone.


Subject(s)
Antipsychotic Agents/therapeutic use , Hippocampus/pathology , Risperidone/therapeutic use , Schizophrenia/pathology , Adult , Algorithms , Body Weight/physiology , Female , Functional Laterality/physiology , Humans , Magnetic Resonance Imaging , Male , Models, Neurological , Psychiatric Status Rating Scales
8.
J Psychiatr Res ; 36(5): 309-15, 2002.
Article in English | MEDLINE | ID: mdl-12127598

ABSTRACT

Evidence is accumulating for a possible role of nitric oxide (NO) in schizophrenia. Adrenomedullin (AM) induces vasorelaxation by activating adenylate cyclase and also by stimulating the release of NO. AM immune reactivity is present in the brain consistent with a role as neurotransmitter. We aimed to examine plasma levels of nitrite (a metabolite of NO) and AM in schizophrenic patients. Eighty-two patients with schizophrenia and 21 healthy control subjects were included in this study. DSM-IV diagnosis of chronic schizophrenia was established on the basis of independent structured clinical interviews and review of records by two qualified psychiatrists which included the Brief Psychiatric Rating Scale (BPRS), The Scale for the Assessment of Negative Symptoms (SANS) and The Scale for the Assessment of Positive Symptoms (SAPS). Total nitrite and AM have been studied in plasma. The mean values of plasma nitrite and AM levels in schizophrenic group were significantly higher than control values, respectively (P=0.03, P<0.0001). AM levels of schizophrenic patients were three fold higher than controls. In correlation analyses, there were statistically significant positive correlations between AM level and SAPS-delusion subscale (r=0.27, P=0.04); SAPS-bizarre behavior subscale (r=0.28, P=0.03) and SAPS-total (r=0.36, P=0.005). There is no correlation between total nitrite and AM levels (r=0.11, P=0.31). Both NO and AM may have a pathophysiological role in schizophrenia, and clinically symptomatology and prognosis of schizophrenia. This subject needs further study including treatment response and subtypes of schizophrenia.


Subject(s)
Brain/physiopathology , Nitric Oxide/blood , Peptides/blood , Schizophrenia/blood , Schizophrenia/physiopathology , Adolescent , Adrenomedullin , Adult , Brain/metabolism , Brief Psychiatric Rating Scale , Chronic Disease , Female , Humans , Male , Middle Aged , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...